The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

Pfizer made one thing clear this week: It's officially back in the obesity race.

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...

Only four of 66 undesirable outcomes attributed to statins were significant, according to a new study in the Lancet.

Bayer can now offer its Stryax herbicide following government approval. The Environmental Protection Agency registered low-volatility dicamba herbicides in 34 states, which opens the door for Bayer to ...

It has straight-line speed, but we can’t help but feel the absence of something in the new Charger.

Menopause clinics across the U.S. are hearing from women who are having trouble filling prescriptions for estrogen patches, a common hormone replacement therapy.

The FDA grants Fast Track designation to sonelokimab for moderate to severe palmoplantar pustulosis, a chronic inflammatory skin disease.